MONOCLONAL ANTIBODY AGAINST HUMAN MAC-1 AND USES THEREOF

BISPECIFIC ANTI-CD3 ANTIBODIES, BISPECIFIC ACTIVATABLE ANTI-CD3 ANTIBODIES, AND METHODS OF USING THE SAME

SINGLE CHAIN VARIABLE FRAGMENT CD3 BINDING PROTEINS

HUMANIZED AND CHIMERIC MONOCLONAL ANTIBODIES TO CD47

TREATMENT OF CANCER USING CHIMERIC CD3 RECEPTOR PROTEINS

T CELL RECEPTORS AND USES THEREOF

ANTI-CD123 BINDING MOLECULES AND USES THEREOF

Antibody variable domains targeting the NKG2D receptor

Antibody variable domains targeting the NKG2D receptor

ANTI-CD166 ANTIBODIES, ACTIVATABLE ANTI-CD166 ANTIBODIES, AND METHODS OF USE THEREOF

Antibody variable domains targeting the NKG2D receptor

COMPOSITIONS AND METHODS FOR TARGETING AND KILLING ALPHA-V BETA-3-POSITIVE CANCER STEM CELLS (CSCS) AND TREATING DRUG RESISTANT CANCERS

MICA/B ANTIBODIES AND METHODS OF USE

Compositions and Methods for Treating Cancer with Anti-CD19 Immunotherapy

ANTI-HUMAN VISTA ANTIBODIES AND USE THEREOF

DUAL-SPECIFIC APTAMER TRIGGERING CELL-MEDIATED CYTOTOXICITY TO LYSE HER2-POSITIVE CANCER CELLS

METHODS OF INDUCING IMMUNE TOLERANCE WITH MODIFIED ANTI-CD154 ANTIBODIES

MULTIVALENT BINDING MOLECULES

DIAGNOSIS AND THERAPY OF CANCER INVOLVING CANCER STEM CELLS

MULTI-PARATOPIC ANTI-PD-1 ANTIBODIES AND USES THEREOF

NUCLEIC ACID BIOMARKER AND USE THEREOF

ANTI-GPC3 ANTIBODIES, MULTISPECIFIC ANTIBODIES AND METHODS OF USE

ANTIBODY DRUG CONJUGATES (ADC) THAT BIND TO 158P1D7 PROTEINS

PEPTIDE COMPOSITIONS AND METHODS FOR ANTI-CD3 BINDING DOMAINS

Anti-SARS-CoV-2-Spike Glycoprotein Antibodies and Antigen-Binding Fragments

Methods and compositions for dosing of allogeneic chimeric antigen receptor T cells

COMPOSITIONS AND METHODS RELATED TO TUMOR ACTIVATED ANTIBODIES TARGETING TROP2 AND EFFECTOR CELL ANTIGENS

COMPOSITIONS AND METHODS FOR TREATING CANCER WITH ANTI-CD19/CD20 IMMUNOTHERAPY

COMPOSITIONS AND METHODS OF TREATING LUPUS NEPHRITIS

METHOD OF TREATING CANCER COMPRISING ADMINISTRATION OF ANTI-HER2 ANTIBODY-DRUG CONJUGATE

OPTIMIZED Fc VARIANTS

ANTIBODIES TO CD40 WITH ENHANCED AGONIST ACTIVITY

NPC1 MONOBODIES AND MONOBODY CONJUGATES THEREOF

DIMERIZING AGENT REGULATED IMMUNORECEPTOR COMPLEXES

IMMUNOTHERAPEUTIC VACCINE AND ANTIBODY COMBINATION THERAPY

COMPOSITIONS AND METHODS FOR DETECTING AND TREATING OVARIAN CANCER

ANTIBODIES SPECIFIC TO HUMAN POLIOVIRUS RECEPTOR (PVR)

ANTIBODIES BINDING TO CD3 AND PLAP

ROR1 BINDING PROTEIN AND USE THEREOF

CD3 BINDING ANTIBODIES

FUSION MOLECULE HAVING NON-INFLAMMATORY PHAGOCYTOSIS INDUCING ACTIVITY

METHODS AND COMPOSITIONS FOR DEPLETING NATURAL KILLER CELLS AND USES THEREOF IN CELLULAR THERAPIES

Antibody Constructs for CDH19 and CD3

Dynamic I/O virtualization system having guest memory management for mapping virtual addresses using virtualization application programming interface (API) in guest kernal

Coronavirus Spike Protein-Specific Antibody and Use Thereof

Compositions and Methods for Targeting Stromal Cells for the Treatment of Cancer

Bispecific antibody binding BCMA and CD3

ANTIBODY BINDING HUMAN IL-5R alpha AND USE THEREOF

ANTI-MET ANTIBODIES, BISPECIFIC ANTIGEN BINDING MOLECULES THAT BIND MET, AND METHODS OF USE THEREOF

SELECTIVE ELIMINATION OF EROSIVE CELLS

IMMUNOSILENCING Fc VARIANTS

ANTI-CD40 ANTIBODIES AND METHODS OF USE

POLYPEPTIDE CONSTRUCTS BINDING TO CD3

Twin Immune Cell Engager

ANTI-IL5 NANOANTIBODY AND USE THEREOF

BISPECIFIC ANTI-VEGF/ANTI-ANG-2 ANTIBODIES

NEUTRALIZING ANTIBODIES AGAINST SARS-COV-2

MULTISPECIFIC BINDING PROTEINS TARGETING CEA

MONOCLONAL ANTIBODIES TO GROWTH AND DIFFERENTIATION FACTOR 15 (GDF-15), AND USESTHEREOF FOR TREATING CANCER CACHEXIA AND CANCER

POLY-N-ACETYL GLUCOSAMINE (PNAG/DPNAG)-BINDING PEPTIDES AND METHODS OF USE THEREOF

BINDING MOLECULES THAT MULTIMERISE CD45

ANTIBODIES SPECIFICALLY RECOGNIZING INTERLEUKIN-4 RECEPTOR ALPHA AND USES THEREOF

Anti-MUC1 antibody-drug conjugate

ANTI-C-MET ANTIBODY DRUG CONJUGATES

METHODS AND COMPOSITIONS INVOLVING INTERLEUKIN-6 RECEPTOR ALPHA-BINDING SINGLE CHAIN VARIABLE FRAGMENTS

HETERODIMERIC ANTIBODIES THAT BIND CD3 AND TUMOR ANTIGENS

ANTI-ERBB3 ANTIBODIES

IMMUNOSILENCING Fc VARIANTS

TIM-3-targeting antibodies and uses thereof

Materials And Methods For Binding Siglec-3/CD33

Materials And Methods For Binding Siglec-3/CD33

CD33 ANTIBODIES

Anti-PfRH5 antibodies and antigen-binding fragments thereof

ANTI-IDIOTYPE COMPOSITIONS AND METHODS OF USE THEREOF

ANTIGEN BINDING PROTEINS SPECIFICALLY BINDING PRAME

HUMANIZED ANTIBODY, CHIMERIC ANTIGEN RECEPTOR, NUCLEIC ACID, VECTOR, CELL AND USE

PROTEASE CLEAVABLE BISPECIFIC ANTIBODIES AND USES THEREOF

PROTEINS BINDING NKG2D, CD16 AND NECTIN4

TRISPECIFIC ANTI-CD38, ANTI-CD28, AND ANTI-CD3 BINDING PROTEINS AND METHODS OF USE FOR TREATING VIRAL INFECTION

MONOCLONAL ANTIBODIES AND METHODS FOR USING SAME

CHIMERIC ANTIGEN RECEPTORS TARGETED TO PSCA

BISPECIFIC ANTIBODY

ANTI-CANCER PROTEINS

Therapeutic Bacterial Composition

Therapeutic antibodies against ROR-1 protein and methods for use of same

BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES

Immune cells having co-expressed shRNAS and logic gate systems

COMPOSITION OF TRIAX ANTIBODIES AND METHOD OF MAKING AND USING THEREOF

NOVEL ANTI-LILRB4 ANTIBODIES AND DERIVATIVE PRODUCTS

Vaccine Compositions and Antibodies For Lyme Disease

METHODS AND COMPOSITIONS FOR TREATING SYSTEMIC MASTOCYTOSIS

MONOCLONAL ANTIBODIES AGAINST BCMA

Antagonistic CD40 Monoclonal Antibodies and Uses Thereof

Anti-alpha-v integrin antibody for the treatment of fibrosis and/or fibrotic disorders

MULTI-SPECIFIC ANTIBODIES AND METHODS OF MAKING AND USING THEREOF

Cytotoxic and anti-mitotic compounds, and methods of using the same

EPHB2 ANTIBODY AND USE THEREOF IN COMBINATION THERAPY

ANTIBODY CONSTRUCTS FOR DLL3 AND CD3

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AND METHODS FOR GENERATING SCAFFOLDS FOR THE USE AGAINST PANCREATIC CANCER AND OTHER CANCERS

CHIMERIC ANTIGEN RECEPTORS (CAR) AND METHODS FOR MAKING AND USING THE SAME

ANTI-TRKA ANTIBODY OR ANTIGEN-BINDING FRAGMENT THEREOF, PREPARATION METHOD THEREOF, AND APPLICATION THEREOF

Methods for treating myeloma by achieving therapeutically effective doses of anti-CD47 antibody

CLAUDIN-18.2-SPECIFIC IMMUNORECEPTORS AND T CELL EPITOPES

MUC1* ANTIBODIES

Chimeric polypeptide assembly and methods of making and using the same

ANTAGONISTIC ANTI-TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY POLYPEPTIDES

CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF

ANTIBODIES AGAINST HUMAN AND CANINE IL-13RA2

ANTIBODIES SPECIFIC TO DELTA 1 CHAIN OF T CELL RECEPTOR

Anti-fungal polypeptides

CD37-BINDING MOLECULES IMMUNOCONJUGATES THEREOF

ANTI-PD-L1 ANTIBODIES, COMPOSITIONS AND ARTICLES OF MANUFACTURE

ANTI-TREM2 ANTIBODIES AND RELATED METHODS

ANTI-FAM19A5 ANTIBODIES AND USES THEREOF

TGF-β3 specific antibodies and methods and uses thereof

HUMANIZED ANTI-IL-4Ra SINGLE DOMAIN ANTIBODY AND APPLICATION THEREOF

ANTI-TIM3 ANTIBODIES AND METHODS OF USE

VEGF/DLL4 BINDING AGENTS AND USES THEREOF

Modified Monocytes/Macrophage Expressing Chimeric Antigen Receptors and Uses Thereof

MDR immunogen

ANTIBODY CONSTRUCTS FOR FLT3 AND CD3

Anti-MUC16 Antibodies, Antibody-Drug Conjugates, and Bispecific Antigen-Binding Molecules that Bind MUC16 and CD3, and Uses Thereof

ANTI-LAG-3 ANTIBODIES

FORMULATIONS OF CD38 ANTIBODIES AND USES THEREOF

Monoclonal Antibodies to Programmed Death 1 (PD-1)

Anti-Angiopoietin-2 Antibodies and Uses Thereof

ANTI-MUTANT CALRETICULIN (CALR) ANTIBODIES AND USES THEREOF

ANTIBODY AGAINST NECTIN-4 AND APPLICATION THEREOF

COMPOSITION FOR OVERCOMING RESISTANCE TO EGFR-TARGETING AGENT

Chimeric antigen receptors against multiple HLA-G isoforms

MEANS AND METHODS FOR COUNTERACTING MYELOPROLIFERATIVE OR LYMPHOPROLIFERATIVE DISORDERS

ANTI-BCMA ANTIBODY, PHARMACEUTICAL COMPOSITION OF SAME, AND APPLICATIONS THEREOF

ANTI-SIRPg Compounds

MULTIFUNCTIONAL IMMUNOTHERAPEUTIC MONOCLONAL ANTIBODY COMPLEXES AND CONJUGATES

HUMANIZED ANTIBODIES AGAINST LEWIS Y

Binding Members to PD-L1

MONOCLONAL ANTIBODIES AGAINST LILRB1 FOR DIAGNOSTIC AND THERAPEUTIC USE

CONDITIONALLY ACTIVE ANTI-NECTIN-4 ANTIBODIES

HUMANIZED CD19 ANTIBODY AND USE THEREOF

Compositions and methods for TCR reprogramming using fusion proteins

TUMOR SELECTIVE MACROPINOCYTOSIS-DEPENDENT RAPIDLY INTERNALIZING ANTIBODIES

METHODS AND COMPOSITIONS FOR INHIBITING CD32B EXPRESSING CELLS IN IGG4-RELATED DISEASES

PD-L1-SPECIFIC ANTIBODY AND ANTI-PD-L1-CAR-T CELLS

ONCOLYTIC VIRUS COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER

ANTIBODIES AGAINST HUMAN ANGIOPOIETIN 2

COMPOSITIONS AND METHODS FOR TREATMENT OF CANCER

TREATMENT OF CANCER USING A CD123 CHIMERIC ANTIGEN RECEPTOR

BISPECIFIC HETERODIMERIC FUSION PROTEINS CONTAINING IL-15 - IL-15Ralpha Fc-FUSION PROTEINS AND IMMUNE CHECKPOINT ANTIBODY FRAGMENTS

Chimeric Antigen Receptor (CAR) Comprising A CD19-Binding Domain

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AND METHODS FOR GENERATING SCAFFOLDS FOR THE USE AGAINST PANCREATIC CANCER AND OTHER CANCERS

ANTI-NTB-A ANTIBODIES AND RELATED COMPOSITIONS AND METHODS

PROTEASE-ACTIVATABLE BISPECIFIC PROTEINS

TRISPECIFIC ANTIBODIES SPECIFIC FOR HER2 AND A BLOOD BRAIN BARRIER RECEPTOR AND METHODS OF USE

BISPECIFIC FC MOLECULES

COMPLEMENTARITY-DETERMINING REGIONS FOR BINDING CD3, AND BISPECIFIC ANTIGEN-BINDING MOLECULE CONTAINING SAID CDRS

CYSTEINE LINKED NANOBODY DIMERS

ANTIGEN BINDING POLYPEPTIDES, ANTIGEN BINDING POLYPEPTIDE COMPLEXES AND METHODS OF USE THEREOF

RECOMBINANT MONOCLONAL ANTIBODIES AND CORRESPONDING ANTIGENS FOR COLON AND PANCREATIC CANCERS

TUMOR NECROSIS FACTOR (TNF) SUPERFAMILY RECEPTOR IGM ANTIBODIES AND USES THEREOF

Anti-CSF1R Molecules and Use Thereof

ROR1-SPECIFIC ANTIGEN BINDING MOLECULES

Antibodies to L-type voltage gated channels and related methods

COMBINATION THERAPY FOR CANCER TREATMENT

Anti-LY6H antibodies and antibody drug conjugates

BISPECIFIC T CELL ENGAGING ANTIBODY CONSTRUCTS

Antibody binding specifically to CD40 and use thereof

ANTI-BTLA ANTIBODY PHARMACEUTICAL COMPOSITION AND USE THEREOF

THERAPEUTIC CD47 ANTIBODIES

CLAUDIN18.2 BINDING MOIETIES AND USES THEREOF

Antibody and use thereof

TCR COMPOUNDS, COMPOSITIONS, AND METHODS OF TREATING

ANTI-CD25 ANTIBODIES, ANTIGEN-BINDING FRAGMENTS THEREOF, AND MEDICAL USES THEREOF

SIRP ALPHA AND SIRP BETA 1 ANTIBODIES AND USES THEREOF

NUCLEOLIN-MEDIATED CANCER DIAGNOSTICS AND THERAPY

ANTIBODY-DRUG CONJUGATES

Bispecific Molecules That Are Immunoreactive With Immune Effector Cells That Express An Activating Receptor And An Antigen Expressed By A Cell Infected By A Virus And Uses Thereof

MULTISPECIFIC ANTIBODY AND METHOD FOR PRODUCING SAME

ANTI-CD3-BINDING DOMAINS AND ANTIBODIES COMPRISING THEM, AND METHODS FOR THEIR GENERATION AND USE

HUMANIZED ANTIBODY AGAINST O-ACETYLATED GD2 GANGLIOSIDE (OACGD2)

Phage-displayed accessible recombinant targeted antibodies and methods of making same

Anti-MUC1 antibody-drug conjugate

ANTIGEN BINDING PROTEINS

BISPECIFIC ANTIBODIES AGAINST CEACAM5 AND CD3

Immunoconjugates

CLDN18.2-TARGETING ANTIBODY, BISPECIFIC ANTIBODY AND USE THEREOF

COMPOSITIONS AND METHODS FOR IMMUNE-MEDIATED CANCER THERAPY

Anti-DR5 antibody and use thereof

PSMA Binding Antibody and Uses Thereof

CD7-CAR-T CELL AND PREPARATION AND APPLICATION THEREOF

BISPECIFIC COMBINATION THERAPY FOR TREATING PROLIFERATIVE DISEASES AND AUTOIMMUNE DISEASES

PROTEINS SPECIFIC FOR BAFF AND B7RP1 AND USES THEREOF

Selective immunodepletion of endogenous stem cell niche for engraftment

Anti-TREM1 antibodies and methods of use thereof

Bispecific antigen binding constructs targeting HER2

D glutamate polyglutamated antifolates and uses thereof

ANTI-EGFR ANTIBODY DRUG CONJUGATES

ANTI-CD276 POLYPEPTIDES, PROTEINS, AND CHIMERIC ANTIGEN RECEPTORS

Antibodies and vaccines for use in treating ROR1 cancers and inhibiting metastasis

ANTI-FUNGAL POLYPEPTIDES

POLYPEPTIDE VARIANTS AND USES THEREOF

ANTI-NTB-A ANTIBODIES AND RELATED COMPOSITIONS AND METHODS

CD38 MODULATING ANTIBODY AGENTS

NOVEL COMPOSITIONS AND METHODS FOR THE TREATMENT OF IMMUNE RELATED DISEASES

METHODS FOR TREATING CANCER OR INFECTION USING A COMBINATION OF AN ANTI-PD-1 ANTIBODY, AN ANTI-CTLA4 ANTIBODY, AND AN ANTI-TIGIT ANTIBODY

Selective drug release from internalized conjugates of biologically active compounds

Antigen binding proteins specifically binding PRAME

Bacterial Biomarker

ANTI-PD-L1 ANTIBODIES

DESIGN AND DEVELOPMENT OF MASKED THERAPEUTIC ANTIBODIES TO LIMIT OFF-TARGET EFFECTS

Anti-O2 antibodies and uses thereof

ANTI-MULLERIAN HORMONE RECEPTOR 2 ANTIBODIES AND METHODS OF USE

Antibodies to TGF-Beta

Method for the treatment or prevention of infection-related immune conditions using a composition comprising IgM

Immunoconjugates

CD3/CD38 T cell retargeting hetero-dimeric immunoglobulins and methods of their production

Methods for Determining the Likelihood of Survival and for Predicting Likelihood of Metastasis in Cancer Patients

Antibodies specific for FLT3 and their uses

CLAUDIN-6 BINDING MOLECULES AND USES THEREOF

V-C-FC-V-C ANTIBODY

NOVEL ANTI-FGFR2B ANTIBODIES

ANTIBODIES AGAINST GLUCOCORTICOID-INDUCED TUMOR NECROSIS FACTOR RECEPTOR (GITR) AND USES THEREOF

PHOTOSENSITIZING ANTIBODY-FLUOROPHORE CONJUGATES

Chimeric antigen receptors targeting B-cell maturation antigen

Antibodies, activatable antibodies, bispecific antibodies, and bispecific activatable antibodies and methods of use thereof

CONSTRUCTS SPECIFICALLY RECOGNIZING GLYPICAN 3 AND USES THEREOF

Antibodies against MFAP4

Pertuzumab variants and evaluation thereof

BISPECIFIC ANTIBODIES AGAINST CHI3L1 AND CTLA4 WITH ENHANCED CYTOTOXIC EFFECTS ON TUMOR CELLS

COMPOSITIONS AND METHODS FOR MAKING ANTIBODY CONJUGATES

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AND METHODS FOR GENERATING SCAFFOLDS FOR THE USE AGAINST PANCREATIC CANCER AND OTHER CANCERS

Determining WT-1-Specific T Cells and WT-1 Specific T Cell Receptors (TCRS)

Bispecific antibody constructs for CDH3 and CD3

Anti-HER2 Antibodies and Immunoconjugates

ANTIBODIES HAVING SPECIFICITY TO HER4 AND USES THEREOF

COMPOSITIONS AND METHODS OF TREATING LUPUS NEPHRITIS

ANTI-CD19 ANTIBODIES AND MULTI-SPECIFIC BINDING PROTEINS

Chimeric antigen receptors targeting B-cell maturation antigen

HUMANIZED CLDN18.2 ANTIBODIES

Compositions and Methods for Targeting Cancer Stem Cells

GRP78-binding antibodies and uses thereof in detecting or neutralizing GRP78

TARGETING GENE AMPLIFICATION IN CANCER USING TRIPLEX FORMATION AS A THERAPEUTIC STRATEGY

HUMANIZED OR CHIMERIC CD3 ANTIBODIES

ANTI-MUC16 ANTIBODIES AND USES THEREOF

Chimeric Antigen Receptor and Natural Killer Cells Expressing Same

CHIMERIC ANTIGEN RECEPTOR TO WHICH ANTI-COTININE ANTIBODY IS LINKED, AND USE THEREOF

Chimeric antigen receptors targeting B-cell maturation antigen

ANTI-CD3 ANTIBODIES AND METHODS OF USE

INSERTABLE VARIABLE FRAGMENTS OF ANTIBODIES AND MODIFIED A1-A2 DOMAINS OF NKG2D LIGANDS

MULTISPECIFIC ANTIBODY

Antibodies binding to HLA-A2/WT1

Antibodies targeting an amphiregulin-derived cell surface neo-epitope

Antibodies that bind to OX40 and their uses

ANTI-DEATH RECEPTOR ANTIBODIES AND METHODS OF USE THEREOF

SYSTEMS AND METHODS FOR TARGETING CANCER CELLS

Heterodimeric antibodies that bind CD3 and CD38

MULTITARGETING ANTIGEN-BINDING MOLECULES FOR USE IN PROLIFERATIVE DISEASES

THERAPEUTIC USES OF ANTI-TCR DELTA VARIABLE 1 ANTIBODIES

TRISPECIFIC BINDING MOLECULES AGAINST BCMA AND USES THEREOF

RAGE ANTIBODIES, FRAGMENTS AND USES THEREOF

HIGH AFFINITY ANTIBODIES TO CD39 AND USES THEREOF

HUMANIZED OR CHIMERIC CD3 ANTIBODIES

Polypeptides comprising immunoglobulin chain variable domains which bind to interleukin-6 receptor (IL-6R) and methods of use thereof to treat autoimmune and inflammatory diseases

HUMANIZED OR CHIMERIC CD3 ANTIBODIES

TRANSGENE GENETIC TAGS AND METHODS OF USE

Anti-c-Met antibody drug conjugates

ANTIGEN BINDING PROTEINS SPECIFICALLY BINDING PRAME

Anti-CD123 antibodies and conjugates and derivatives thereof

Human antibodies binding to ROR2

DEFINED COMPOSITION GENE MODIFIED T-CELL PRODUCTS

Polyglutamated antifolates and uses thereof

CD123 binding proteins and related compositions and methods

ANTI-TIM3 ANTIBODIES AND METHODS OF USE

ANTI-BCMA ANTIBODY CONJUGATES

Uses of indolinone compounds

Binding molecules for BCMA and CD3

Human anti-semaphorin 4D antibody

ROR1 specific chimeric antigen receptors and their therapeutic applications

Humanized, mouse or chimeric anti-CD47 monoclonal antibodies

METHODS OF ENGINEERING PLATELETS FOR TARGETING CIRCULATING TUMOR CELLS

ENHANCED IMMUNE CELLS USING DUAL SHRNA AND COMPOSITION INCLUDING THE SAME

GRP78-binding antibodies and uses thereof in detecting or neutralizing GRP78

RECOMBINANT ANTIBODIES, PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME, AND USES THEREOF

COMPOUND CHIMERIC ANTIGEN RECEPTOR (cCAR) TARGETING MULTIPLE ANTIGENS, COMPOSITIONS AND METHOD OF USE THEREOF

ANTI-CEACAM5 ANTIBODIES AND USES THEREOF

Chimeric antigen receptors targeting B-cell maturation antigen

ANTIBODY-DRUG CONJUGATES THAT TARGET DLK1 AND USES THEREOF

HETERODIMERIC PROTEINS AND METHODS FOR PRODUCING AND PURIFYING THEM

ANTIBODIES AND METHOD OF PRODUCING ANTIBODIES

METHODS OF TREATING CANCER

TRIFUNCTIONAL T CELL-ANTIGEN COUPLER AND METHODS AND USES THEREOF

ANTI-SIGLEC-8 ANTIBODIES AND METHODS OF USE THEREOF

Activatable Multi-Specific Antigen Binding Protein Complexes

Markers of acute myeloid leukemia stem cells

ANTIBODIES AND CHIMERIC ANTIGEN RECEPTORS THAT TARGET TACI

ANTI-MÜLLERIAN INHIBITING SUBSTANCE ANTIBODIES AND USES THEREOF

ANTI-CONNECTIVE TISSUE GROWTH FACTOR ANTIBODY AND APPLICATION THEREOF

ANTI-HER2 AFFIBODY AND SWITCHABLE CHIMERIC ANTIGEN RECEPTOR USING SAME AS SWITCH MOLECULE

Conditionally active anti-EpCAM antibodies, antibody fragments, their immunoconjugates and uses thereof

Trispecific antibody targeting CD79b, CD20, and CD3

Anti-Siglec-5 antibodies and methods of use thereof